rc 3095 has been researched along with Injury, Ischemia-Reperfusion in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrade, CF; De Angelis, K; Malfitano, C; Oliveira-Freitas, VL; Schwartsmann, G; Simoneti, LE; Thomaz, LD; Ulbrich, JM | 1 |
| Gralla, O; Heuser, M; Nustede, R; Post, S | 1 |
| Gralla, O; Gröne, HJ; Heuser, M; Nustede, R; Pfaar, O; Post, S | 1 |
3 other study(ies) available for rc 3095 and Injury, Ischemia-Reperfusion
| Article | Year |
|---|---|
RC-3095, a selective gastrin-releasing peptide receptor antagonist, does not protect the lungs in an experimental model of lung ischemia-reperfusion injury.
Topics: Animals; Antineoplastic Agents; Bombesin; Disease Models, Animal; Interleukin-1beta; Lung; Lung Diseases; Male; Nitric Oxide Synthase Type III; Peptide Fragments; Rats; Rats, Wistar; Receptors, Bombesin; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2015 |
[Significance of regulatory peptide GRP for microcirculation of the small intestine after ischemia/reperfusion].
Topics: Animals; Blood Flow Velocity; Bombesin; Gastrin-Releasing Peptide; Intestine, Small; Ischemia; Microcirculation; Peptide Fragments; Rats; Rats, Wistar; Reperfusion Injury | 1998 |
Impact of gastrin-releasing peptide on intestinal microcirculation after ischemia-reperfusion in rats.
Topics: Analysis of Variance; Animals; Antineoplastic Agents; Bombesin; Female; Gastrin-Releasing Peptide; Injections, Intravenous; Intestines; Ischemia; Microcirculation; Microscopy, Fluorescence; Peptide Fragments; Rats; Rats, Wistar; Reperfusion Injury | 2000 |